Logo for CVRx Inc

CVRx Investor Relations Material

Latest events

Logo for CVRx Inc

Q4 2023

CVRx
Logo for CVRx

Q4 2023

25 Jan, 2024
Logo for CVRx

Q3 2023

26 Oct, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from CVRx Inc

Access all reports
CVRx develops and commercializes neuromodulation solutions for patients with heart failure. CVRx's first product, Barostim, is a investigational device that delivers low-energy electrical stimulation to the left ventricle through cardiac leads inserted into veins that leave the left ventricle.